Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids
The use of synthetic cannabinoids (SCBs) is associated with many severe adverse effects that are not observed with marijuana use. We report a unique case of a patient who developed rhabdomyolysis and acute kidney injury (AKI) requiring dialysis after use of SCBs combined with quetiapine. Causes for...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Nephrology |
| Online Access: | http://dx.doi.org/10.1155/2015/235982 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564738443182080 |
|---|---|
| author | Aiyu Zhao Maybel Tan Aung Maung Moro Salifu Mary Mallappallil |
| author_facet | Aiyu Zhao Maybel Tan Aung Maung Moro Salifu Mary Mallappallil |
| author_sort | Aiyu Zhao |
| collection | DOAJ |
| description | The use of synthetic cannabinoids (SCBs) is associated with many severe adverse effects that are not observed with marijuana use. We report a unique case of a patient who developed rhabdomyolysis and acute kidney injury (AKI) requiring dialysis after use of SCBs combined with quetiapine. Causes for the different adverse effects profile between SCBs and marijuana are not defined yet. Cases reported in literature with SCBs use have been associated with reversible AKI characterized by acute tubular necrosis and interstitial nephritis. Recent studies have showed the involvement of cytochromes P450s (CYPs) in biotransformation of SCBs. The use of quetiapine which is a substrate of the CYP3A4 and is excreted (73%) as urine metabolites may worsen the side effect profiles of both quetiapine and K2. SCBs use should be included in the differential diagnosis of AKI and serum Creatinine Phosphokinase (CPK) level should be monitored. Further research is needed to identify the mechanism of SCBs nephrotoxicity. |
| format | Article |
| id | doaj-art-2cbb02c9496c4a42941d6686b71021e5 |
| institution | Kabale University |
| issn | 2090-6641 2090-665X |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Nephrology |
| spelling | doaj-art-2cbb02c9496c4a42941d6686b71021e52025-02-03T01:10:18ZengWileyCase Reports in Nephrology2090-66412090-665X2015-01-01201510.1155/2015/235982235982Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic CannabinoidsAiyu Zhao0Maybel Tan1Aung Maung2Moro Salifu3Mary Mallappallil4State University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USAState University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USAState University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USAState University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USAState University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USAThe use of synthetic cannabinoids (SCBs) is associated with many severe adverse effects that are not observed with marijuana use. We report a unique case of a patient who developed rhabdomyolysis and acute kidney injury (AKI) requiring dialysis after use of SCBs combined with quetiapine. Causes for the different adverse effects profile between SCBs and marijuana are not defined yet. Cases reported in literature with SCBs use have been associated with reversible AKI characterized by acute tubular necrosis and interstitial nephritis. Recent studies have showed the involvement of cytochromes P450s (CYPs) in biotransformation of SCBs. The use of quetiapine which is a substrate of the CYP3A4 and is excreted (73%) as urine metabolites may worsen the side effect profiles of both quetiapine and K2. SCBs use should be included in the differential diagnosis of AKI and serum Creatinine Phosphokinase (CPK) level should be monitored. Further research is needed to identify the mechanism of SCBs nephrotoxicity.http://dx.doi.org/10.1155/2015/235982 |
| spellingShingle | Aiyu Zhao Maybel Tan Aung Maung Moro Salifu Mary Mallappallil Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids Case Reports in Nephrology |
| title | Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids |
| title_full | Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids |
| title_fullStr | Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids |
| title_full_unstemmed | Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids |
| title_short | Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids |
| title_sort | rhabdomyolysis and acute kidney injury requiring dialysis as a result of concomitant use of atypical neuroleptics and synthetic cannabinoids |
| url | http://dx.doi.org/10.1155/2015/235982 |
| work_keys_str_mv | AT aiyuzhao rhabdomyolysisandacutekidneyinjuryrequiringdialysisasaresultofconcomitantuseofatypicalneurolepticsandsyntheticcannabinoids AT maybeltan rhabdomyolysisandacutekidneyinjuryrequiringdialysisasaresultofconcomitantuseofatypicalneurolepticsandsyntheticcannabinoids AT aungmaung rhabdomyolysisandacutekidneyinjuryrequiringdialysisasaresultofconcomitantuseofatypicalneurolepticsandsyntheticcannabinoids AT morosalifu rhabdomyolysisandacutekidneyinjuryrequiringdialysisasaresultofconcomitantuseofatypicalneurolepticsandsyntheticcannabinoids AT marymallappallil rhabdomyolysisandacutekidneyinjuryrequiringdialysisasaresultofconcomitantuseofatypicalneurolepticsandsyntheticcannabinoids |